Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Karen C. Chung"'
Autor:
Karen C. Chung, Anushini Muthutantri, Grace G. Goldsmith, Megan R. Watts, Audrey E. Brown, Donald L. Patrick
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-23 (2024)
Abstract Background Cancer stage at diagnosis is an important prognostic indicator for patient outcomes, with detection at later stages associated with increased mortality and morbidity. The impact of cancer stage on patient-reported outcomes is poor
Externí odkaz:
https://doaj.org/article/3121e47af9874e92b59d0081de18630d
Autor:
Sabrina Ilham, Connor Willis, Kibum Kim, Karen C. Chung, Brenda M. Wood, Malinda S. Tan, Chia Jie Tan, Danielle T. Nguyen, Diana I. Brixner, David D. Stenehjem
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Diminished immune defense plays an important role in cancer development. Cancer risk in immunocompromised patients may differ. Identifying individuals with elevated cancer risk can inform strategies for routine cancer screening. T
Externí odkaz:
https://doaj.org/article/df04794d92ed426abdca967c73ed8622
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Cancer represents a significant source of disease burden in the United States (US), both clinically and economically. Diagnosis and treatment of cancer at earlier stages may reduce this burden. To better understand potential impac
Externí odkaz:
https://doaj.org/article/0142e5204913434b98771e997aaea951
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-23 (2022)
Abstract Background Multi-cancer early detection tests have been developed to enable earlier detection of multiple cancer types through screening. As reflected by patient-reported outcomes (PROs), the psychosocial impact of cancer screening is not ye
Externí odkaz:
https://doaj.org/article/c31f0d52e7e8428ebf174a6f990114eb
Publikováno v:
Preventive Medicine Reports, Vol 30, Iss , Pp 102046- (2022)
This study aimed to comprehensively assess breast, colorectal, cervical, lung, and prostate cancer screening rates and trends in the United States over time among individuals for whom screening is recommended by the United States Preventive Services
Externí odkaz:
https://doaj.org/article/d89c0af8d45a4d06b146d52b0646b77e
Autor:
Lincoln D. Nadauld, Charles H. McDonnell, Tomasz M. Beer, Minetta C. Liu, Eric A. Klein, Andrew Hudnut, Richard A. Whittington, Bruce Taylor, Geoffrey R. Oxnard, Jafi Lipson, Margarita Lopatin, Rita Shaknovich, Karen C. Chung, Eric T. Fung, Deborah Schrag, Catherine R. Marinac
Publikováno v:
Cancers, Vol 13, Iss 14, p 3501 (2021)
To examine the extent of the evaluation required to achieve diagnostic resolution and the test performance characteristics of a targeted methylation cell-free DNA (cfDNA)-based multi-cancer early detection (MCED) test, ~6200 participants ≥50 years
Externí odkaz:
https://doaj.org/article/4b0aac4eab8c405cbe20adace24b21f0
Autor:
Heather Gelhorn, Melissa M. Ross, Anuraag R. Kansal, Eric T. Fung, Michael V. Seiden, Nicolas Krucien, Karen C. Chung
Publikováno v:
The Patient - Patient-Centered Outcomes Research. 16:43-56
Autor:
Heather Gelhorn, Melissa Ross, Anuraag R Kansal, Eric T Fung, Michael Seiden, Nicolas Krucien, Karen C Chung
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:HSR22-140
Autor:
Ali Tafazzoli, Scott D. Ramsey, Alissa Shaul, Weicheng Ye, Ameya Chavan, Karen C. Chung, Anuraag R. Kansal, A. Mark Fendrick
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:EPR22-119
Autor:
Allan Hackshaw, Karen C. Chung, Joshua J. Ofman, Heidi Reichert, Sarah S. Cohen, Anuraag R. Kansal
Publikováno v:
British Journal of Cancer
Background Multi-cancer early detection (MCED) next-generation-sequencing blood tests represent a potential paradigm shift in screening. Methods We estimated the impact of screening in the US and UK. We used country-specific parameters for uptake, an